Measures · D07 in 2019 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 03/2018 – 06/2018
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2018. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
- Disaster policy
- Higher measure star (2018-2019) for contracts with 25% or more enrolled affected
From the 2019 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2019 star distribution
Not rated: Plan too new to be measured (120); Plan too small to be measured (103); Plan not required to report measure (11); Not enough data available (2)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2019
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S4607 Merit Health Insurance Company | Magellan Health, Inc. | — | 78 | 1 | −1 | 6 | 0% |
| H3206 Presbyterian Insurance Company, Inc. | Presbyterian Healthcare Services | — | 75 | 1 | 0 | 10 | 0% |
| S5768 WellCare | Centene Corporation | — | 78 | 1 | −1 | 6 | 0% |
| S5921 UnitedHealthcare | UnitedHealth Group, Inc. | 2,326,418 | 78 | 1 | 0 | 6 | 0% |
| H8649 Aetna Medicare | CVS Health Corporation | 1,503 | 77 | 1 | 0 | 8 | 0% |
| H3312 Aetna Medicare | CVS Health Corporation | 105,069 | 77 | 1 | 0 | 8 | 0% |
| H3379 UnitedHealthcare | UnitedHealth Group, Inc. | 102,401 | 78 | 1 | 0 | 7 | 1% |
| H3347 Elderplan | Elderplan, Inc. | 27,294 | 79 | 1 | −1 | 6 | 1% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 79 | 1 | 0 | 6 | 1% |
| H1692 Aetna Medicare | CVS Health Corporation | 21,626 | 79 | 1 | −1 | 6 | 1% |
| H5959 Blue Cross and Blue Shield of Minnesota | Aware Integrated, Inc. | 282,185 | 79 | 1 | — | 6 | 1% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 79 | 1 | 0 | 6 | 1% |
| H3204 Presbyterian Health Plan | Presbyterian Healthcare Services | 52,025 | 79 | 1 | −3 | 6 | 1% |
| H0107 Blue Cross and Blue Shield of Montana | Health Care Service Corporation | 102,207 | 79 | 1 | −1 | 6 | 1% |
| H1894 Wellpoint | Elevance Health, Inc. | 2,322 | 79 | 1 | −1 | 6 | 1% |
| H8506 Moda Health Plan, Inc. | Moda, Inc. | — | 79 | 1 | — | 6 | 1% |
| H2461 Blue Cross and Blue Shield of Minnesota | Aware Integrated, Inc. | 47,007 | 79 | 1 | −2 | 6 | 1% |
| H1969 Regence BlueShield of Idaho | Cambia Health Solutions, Inc. | 0 | 79 | 1 | −3 | 6 | 1% |
| H7245 Premera Blue Cross Medicare Advantage | Premera | — | 79 | 1 | 0 | 6 | 1% |
| H1666 Blue Cross and Blue Shield of NM, TX | Health Care Service Corporation | 15,741 | 80 | 1 | 0 | 5 | 4% |
| R6694 Aetna Medicare | CVS Health Corporation | 899 | 80 | 1 | 0 | 5 | 4% |
| H4922 AgeWell New York | ParkerCare New York, LLC | — | 80 | 1 | 0 | 5 | 4% |
| R5342 UnitedHealthcare | UnitedHealth Group, Inc. | 0 | 80 | 1 | 0 | 5 | 4% |
| H3597 Aetna Medicare | CVS Health Corporation | 22,853 | 80 | 1 | 0 | 5 | 4% |
| H6396 CareSource MyCare Ohio (HMO D-SNP) | CareSource | 40,849 | 80 | 1 | — | 5 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |